Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Rizzello RV, Mian M, Cascone G, Boschetti L, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Dal Maso L; AIRTUM Working Group.
Toffolutti F, et al. Among authors: gambino m.
Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023.
Front Oncol. 2023.
PMID: 37346072
Free PMC article.
The incidence and survival models, needed to calculate the completeness index (R) and complete prevalence, were evaluated by likelihood ratio tests and by visual comparison. A sensitivity analysis was conducted to explore the effect on the complete prevalence of using diff …
The incidence and survival models, needed to calculate the completeness index (R) and complete prevalence, were evaluated by likeliho …